Business
Picard Medical Announces Conference Participation During J.P. Morgan Healthcare Conference Week
TUCSON, Ariz., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration (FDA) and Health Canada today announced that today announced its attendance at conferences during the week of the 44th Annual J.P. Morgan Healthcare Conference (“JPM week”) including at LifeSci Advisors’ Corporate Access Event and Li
About this update from Goodwin Plc
[{"type":"image","alt":"Picard Medical, Inc.","displaySize":"","headline":null,"caption":"Picard Medical, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":75,"url":"https://media.zenfs.com/en/globenewswire.com/4e25733b249cfcdd029f5354275c291a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gcgpu3t6z4ZWVpSIwIEbWQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/4e25733b249cfcdd029f5354275c291a","width":300,"height":75}},"lazy":false},{"type":"text","content":"TUCSON, Ariz., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration (FDA) and Health Canada today announced that today announced its attendance at conferences during the week of the 44th Annual J.P. Morgan Healthcare Conference (“JPM week”) including at LifeSci Advisors’ Corporate Access Event and Lifeblood and Goodwin’s CEO-Only MedTech Forum.","length":545,"tagName":"p"},{"type":"text","content":"Information on both events is below.","length":36,"tagName":"p"},{"type":"text","content":"Lifeblood and Goodwin’s MedTech CEO-Only ForumDate: January 12, 2026Format: Invite-only discussion forumLocation: InterContinental, San Francisco, CA","length":157,"tagName":"p"},{"type":"text","content":"LifeSci Advisors 15th Annual Corporate Access Event Date: January 14, 2026Format: One-on-one meetingsLocation: The Beacon Grand, San Francisco, CA","length":159,"tagName":"p"},{"type":"text","content":"To request an in-person meeting with the Picard Medical management team on Wednesday January 14th, either register at LifeSci Partners Corporate Access Event 2026 or contact our LifeSci Partners representative Eric Ribner ([email protected]).","length":254,"tagName":"p"},{"type":"text","content":"About Picard Medical, Inc.Picard Medical, Inc. is the parent company of SynCardia Systems, LLC (“SynCardia”), the Tucson, Arizona–based leader with the only commercially available total artificial heart technology for patients with end-stage heart failure. SynCardia develops, manufactures, and commercializes the SynCardia Total Artificial Heart (“STAH”), an implantable system that assumes the full functions of a ...